Sol Shenker is a mission-driven bioinformatics and software leader specializing in CRISPR informatics and data-driven biology. As CEO of Shenker Bioinformatics, LLC, he guides clients in CRISPR research and cell therapy development, bridging computational and laboratory science to accelerate translational programs and address regulatory feedback for genotoxicity assessments. With 11 years in the biotech space, he previously led computational biology at KSQ Therapeutics, delivering genotox analysis pipelines, AI-driven biomarker discovery, and Agile-enabled software development across discovery and translational workflows. His work spans high-throughput sequencing assays (SITE-seq, GUIDE-seq, UDITAS) and end-to-end data platforms that democratize analysis for bench scientists through reproducible, version-controlled workflows. Sol earned a Ph.D. in Bioinformatics from Memorial Sloan Kettering and a BSc in Biochemistry with a CS minor from McGill, reflecting a strong blend of wet-lab insight and software craft. Based in the Boston area, he combines scientific curiosity with leadership to build scalable, auditable solutions that connect data to biology.
11 years of coding experience
8 years of employment as a software developer
Doctor of Philosophy (Ph.D.), Bioinformatics, Doctor of Philosophy (Ph.D.), Bioinformatics at Memorial Sloan-Kettering Cancer Center
Bachelor’s Degree, Biochemistry, minor Computer Science, Bachelor’s Degree, Biochemistry, minor Computer Science at McGill University
Transcript assembly tool using multiple change-point inference to improve 3'UTR annotation
Contributions:11 releases, 48 commits, 3 PRs in 1 year 9 months
change-pointfeature-extractioninferencepointutr
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.